BNP Paribas Financial Markets
PAVM icon

BNP Paribas Financial Markets’s PAVmed PAVM Stock Holding History

BNP Paribas Financial Markets’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Hold
1
– – ﹤0.01% 5879
2026
Q1 		$10 Hold
1
– – ﹤0.01% 5768
2025
Q4 		$7 Hold
1
– – ﹤0.01% 5700
2025
Q3 		$13 Hold
1
– – ﹤0.01% 5513
2025
Q2 		$18 Buy
+1
New +$20 ﹤0.01% 5397
2023
Q1 		– Hold
0
– -$49 – 4008
2022
Q4 		– Hold
0
– – – 3974
2022
Q3 		– Sell
-12
Closed -$6.8K – 4655
2022
Q2 		$5.07K Sell
12
-1,352
-99% -$653K ﹤0.01% 3822
2022
Q1 		$810K Sell
1,364
-149
-10% -$111K ﹤0.01% 2456
2021
Q4 		$1.67M Buy
1,513
+1,484
+5,117% +$3.23M ﹤0.01% 2192
2021
Q3 		$110K Buy
29
+23
+383% +$72.5K ﹤0.01% 3235
2021
Q2 		$17.7K Sell
6
-12
-67% -$28.3K ﹤0.01% 3561
2021
Q1 		$36.7K Buy
18
+3
+20% +$4.51K ﹤0.01% 3679
2020
Q4 		$14.5K Sell
15
-3
-17% -$2.57K ﹤0.01% 3891
2020
Q3 		$14.4K Buy
18
+15
+500% +$13.3K ﹤0.01% 3914
2020
Q2 		$2.84K Buy
+3
New +$3K ﹤0.01% 4145

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's PAVM Position: Q2 2026 in Review

BNP Paribas Financial Markets held its PAVmed (PAVM) position steady in Q2 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #5879.

BNP Paribas Financial Markets first reported a position in PAVM in Q2 2020 and has held it in 14 quarters since. The position peaked at $1.67M in Q4 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

  • BNP Paribas Financial Markets held 1 share of PAVmed worth $6 as of Q2 2026.
  • BNP Paribas Financial Markets left its PAVmed share count unchanged in Q2 2026.
  • PAVmed made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5879 holding.
  • BNP Paribas Financial Markets first reported a position in PAVmed in Q2 2020 and has held it in 14 quarters since.
  • BNP Paribas Financial Markets's PAVmed position peaked at $1.67M in Q4 2021.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.